{Reference Type}: Journal Article
{Title}: Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.
{Author}: Passiglia F;Pilotto S;Facchinetti F;Bertolaccini L;Del Re M;Ferrara R;Franchina T;Malapelle U;Menis J;Passaro A;Ramella S;Rossi G;Trisolini R;Novello S;
{Journal}: Crit Rev Oncol Hematol
{Volume}: 146
{Issue}: 0
{Year}: Feb 2020
{Factor}: 6.625
{DOI}: 10.1016/j.critrevonc.2019.102858
{Abstract}: The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.